160 related articles for article (PubMed ID: 16213306)
1. Development of malignancy following living donor kidney transplantation.
Nafar M; Einollahi B; Hemati K; Gholi FP; Firouzan A
Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306
[TBL] [Abstract][Full Text] [Related]
2. Malignancy in renal recipients.
Samhan M; Al-Mousawi M; Donia F; Fathi T; Nasim J; Nampoory MR
Transplant Proc; 2005 Sep; 37(7):3068-70. PubMed ID: 16213307
[TBL] [Abstract][Full Text] [Related]
3. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cancer after kidney transplant: results from the North Italy transplant program.
Pedotti P; Cardillo M; Rossini G; Arcuri V; Boschiero L; Caldara R; Cannella G; Dissegna D; Gotti E; Marchini F; Maresca MC; Montagnino G; Montanaro D; Rigotti P; Sandrini S; Taioli E; Scalamogna M
Transplantation; 2003 Nov; 76(10):1448-51. PubMed ID: 14657684
[TBL] [Abstract][Full Text] [Related]
6. Early de novo malignancies after kidney transplantation.
Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
[TBL] [Abstract][Full Text] [Related]
7. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis.
Berber I; Altaca G; Aydin C; Dural A; Kara VM; Yigit B; Turkmen A; Titiz MI
Transplant Proc; 2005 Mar; 37(2):967-8. PubMed ID: 15848593
[TBL] [Abstract][Full Text] [Related]
9. Malignancies after kidney transplantation.
Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
[TBL] [Abstract][Full Text] [Related]
10. Skin malignancies in renal transplant recipients: a Brazilian center registry.
Falsarella PM; Alves-Filho G; Mazzali M
Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
[TBL] [Abstract][Full Text] [Related]
11. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
12. Renal retransplantation: a retrospective monocentric study.
Ott U; Busch M; Steiner T; Schubert J; Wolf G
Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
[TBL] [Abstract][Full Text] [Related]
13. Incidence and types of malignancies in renal transplant recipients in Iraq.
Altaee IK; Jaleel NA; Aljubury HM; Alshamaa IA; Gazala S
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):408-14. PubMed ID: 16970265
[TBL] [Abstract][Full Text] [Related]
14. Development of malignancy following lung transplantation.
Amital A; Shitrit D; Raviv Y; Bendayan D; Sahar G; Bakal I; Kramer MR
Transplantation; 2006 Feb; 81(4):547-51. PubMed ID: 16495802
[TBL] [Abstract][Full Text] [Related]
15. Malignancies following lung transplantation.
Anile M; Venuta F; Diso D; De Giacomo T; Rendina EA; Rolla M; Ruberto F; Liparulo V; Aratari MT; Di Stasio M; Ricella C; Vitolo D; Longo F; Coloni GF
Transplant Proc; 2007; 39(6):1983-4. PubMed ID: 17692672
[TBL] [Abstract][Full Text] [Related]
16. Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience.
Hardinger KL; Schnitzler MA; Koch MJ; Labile E; Stirnemann PM; Miller B; Enkvetchakul D; Brennan DC
Transplantation; 2006 May; 81(9):1285-9. PubMed ID: 16699456
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant malignancies and their relationship with human leukocyte antigens in kidney allograft recipients.
Azmandian J; Lessan-Pezeshki M; Alipour Abedi B; Mahdavi-Mazdeh M; Nafar M; Farhangi S
Iran J Kidney Dis; 2007 Oct; 1(2):98-101. PubMed ID: 19363276
[TBL] [Abstract][Full Text] [Related]
19. Ureteral complications in the renal transplant recipient after laparoscopic living donor nephrectomy.
Fuller TF; Deger S; Büchler A; Roigas J; Schönberger B; Schnorr D; Tüllmann M; Loening SA; Giessing M
Eur Urol; 2006 Sep; 50(3):535-40; discussion 540-1. PubMed ID: 16632185
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of posttransplantation malignancies compared with de novo tumors.
Haberal AN; Süren D; Demirhan B; Bilezikçi B; Celasun B; Haberal M
Transplant Proc; 2007 May; 39(4):1057-62. PubMed ID: 17524891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
